Cochrane Library Editorial - Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19

Pills and pill bottle

During the past 12 months chloroquine and hydroxychloroquine have been touted as cures for COVID-19 and introduced into Covid-19 treatment protocols. This has led to increases in demand, leaving some rheumatoid arthritis and lupus patients deprived of effective treatments.

A newly published Cochrane Library Editorial explores the story of the assessment of chloroquine and hydroxychloroquine efficacy and the lessons learnt. 

Pills and pill bottle

This Editorial publishes alongside the recently published review published in the Cochrane Library  that concludes that hydroxychloroquine  has no clinical benefit in treating COVID-19 in hospitalised patients.

View larger sized visual abstract

Thursday, March 25, 2021
Share/Save